Interference rejection membranes useful with analyte sensors

US11998330B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11998330-B2
Application numberUS-202117162885-A
CountryUS
Kind codeB2
Filing dateJan 29, 2021
Priority dateJan 29, 2021
Publication dateJun 4, 2024
Grant dateJun 4, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the invention provide amperometric analyte sensors having optimized elements such as interference rejection membranes, and associated architectures, as well as methods for making and using such sensors. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of making an amperometric analyte sensor for implantation within a mammal comprising the steps of: providing a first base layer; forming a conductive layer on the first base layer, wherein the conductive layer includes a first working electrode; forming an analyte sensing layer on the conductive layer, wherein the analyte sensing layer includes an enzyme selected to generate a detectable electrical signal upon exposure to an analyte, wherein: the analyte sensing layer is formed by combining a polymerizable monomer, a crosslinking agent and a photoinitiator agent; forming an interference rejection layer on the analyte sensing layer, wherein: the interference rejection layer is formed by a reaction mixture comprising a polymerizable monomer, a crosslinking agent and a photoinitiator agent; the reaction mixture comprises a 15% to 96% of crosslinker to monomer ratio; and the analyte sensing layer and the interference rejection layer are formed when the reaction mixture is polymerized by exposure to light; and forming an analyte modulating layer on the interference rejection layer; such that an amperometric analyte sensor for implantation within a mammal is made. 2. The method of claim 1 , wherein: (a) the reaction mixture forms a polyvinyl alcohol polymer or a poly(2-hydroxyethyl methacrylate) polymer; (b) polymerizable monomer comprises a hydroxyethylmethacrylate monomer, a methyl methacrylate monomer and/or a hydroxybutyl methacrylate monomer; (c) the crosslinking agent comprises an ethylene glycol and/or a silane; and/or (d) relative amounts of crosslinking agent and polymerizable monomer disposed within the reaction mixture are selected such that the reaction mixture comprises 50%-80% crosslinking agent and 20%-50% polymerizable monomer. 3. The method of claim 2 , wherein the analyte sensing layer is formed by combining a polymerizable monomer, a crosslinking agent and a photoinitiator agent and the analyte sensing layer is formed when the reaction mixture is polymerized by exposure to light. 4. The method of claim 1 , wherein: the reaction mixture comprises a diazo photoreactive crosslinking agent; the reaction mixture comprises an ethylene glycol diacrylate crosslinking agent; and/or the method of claim 1 further comprises forming a layer comprising an ascorbic acid oxidase enzyme. 5. The method of claim 4 , wherein: the layer comprising an ascorbic acid oxidase enzyme comprises glucose oxidase or comprises an analyte modulating layer; or the layer comprising an ascorbic acid oxidase enzyme does not comprise glucose oxidase or does not comprise an analyte modulating layer. 6. The method of claim 1 , wherein: the conductive layer includes a second working electrode, wherein said second working electrode comprises an analyte sensing layer and an analyte modulating layer and does not comprise an interference rejection layer; and/or the conductive layer includes a background electrode, wherein said background electrode does not comprise an analyte sensing layer, an analyte modulating layer; or an interference rejection layer. 7. The method of claim 1 , wherein the interference rejection layer is formed in a single step comprising exposure to light. 8. The method of claim 1 , wherein the interference rejection layer is formed in a plurality of steps comprising exposure to light. 9. The method of claim 8 , wherein the plurality of steps comprising exposure to light comprises: a first exposure to light selected to partially polymerize the interference rejection reaction mixture comprising a polymerizable monomer, a crosslinking agent and a photoinitiator agent; and a second exposure to light selected to fully polymerize: the reaction mixture comprising a polymerizable monomer, a crosslinking agent and a photoinitiator agent; and the partially polymerized interference rejection reaction mixture. 10. The method of claim 7 , wherein at least one interference rejection reaction mixture is selectively disposed on a location on the first base layer and/or one photomask is used to selectively polymerize an interference rejection reaction mixture disposed on the first base layer such that contact pads and/or conductor traces disposed on the first base layer do not comprise an interference rejection layer.

Assignees

Inventors

Classifications

  • invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • using correlation, e.g. template matching or determination of similarity · CPC title

  • characterised by the manufacture of electrodes · CPC title

  • using enzyme electrodes, e.g. with immobilised oxidase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11998330B2 cover?
Embodiments of the invention provide amperometric analyte sensors having optimized elements such as interference rejection membranes, and associated architectures, as well as methods for making and using such sensors. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes.
Who is the assignee on this patent?
Medtronic Minimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/14865. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).